BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29080842)

  • 1. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
    Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
    Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
    Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
    Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanisms.
    Alpsoy A; Yasa S; Gündüz U
    Biomed Pharmacother; 2014 Apr; 68(3):351-5. PubMed ID: 24529846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
    Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
    Kim R; Ohi Y; Inoue H; Aogi K; Toge T
    Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
    Kang HJ; Yi YW; Hong YB; Kim HJ; Jang YJ; Seong YS; Bae I
    Sci Rep; 2014 Dec; 4():7201. PubMed ID: 25467193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
    Ohi Y; Kim R; Toge T
    Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
    Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
    Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5'-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs.
    Vinette V; Placet M; Arguin G; Gendron FP
    PLoS One; 2015; 10(8):e0136080. PubMed ID: 26295158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.
    Tang X; Wang H; Fan L; Wu X; Xin A; Ren H; Wang XJ
    Free Radic Biol Med; 2011 Jun; 50(11):1599-609. PubMed ID: 21402146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress.
    Ibbotson K; Yell J; Ronaldson PT
    Fluids Barriers CNS; 2017 Mar; 14(1):6. PubMed ID: 28298215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
    Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
    Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
    Ciamporcero E; Daga M; Pizzimenti S; Roetto A; Dianzani C; Compagnone A; Palmieri A; Ullio C; Cangemi L; Pili R; Barrera G
    Free Radic Biol Med; 2018 Feb; 115():447-457. PubMed ID: 29248722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
    Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
    Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.
    Niture SK; Jaiswal AK
    J Biol Chem; 2012 Mar; 287(13):9873-9886. PubMed ID: 22275372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.